FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up
Dr. Tracy Beth Hoeg, a key FDA official involved in scrutinizing COVID-19 vaccines and antidepressants, has been removed from her position. Her departure follows a series of leadership changes at the FDA, including the resignation of Commissioner Marty Makary. Hoeg's tenure was marked by her controversial views and rapid rise within the agency, despite lacking traditional qualifications for the role.
- ▪Dr. Tracy Beth Hoeg has been removed from her role as the FDA's acting drug center director.
- ▪She will be replaced by Dr. Mike Davis, who previously served as deputy director.
- ▪Hoeg's departure is part of a broader shake-up at the FDA, which has seen multiple leadership changes recently.
Opening excerpt (first ~120 words) tap to expand
ABC NewsLiveVideoShowsGood Morning AmericaShopGMAInterest Successfully AddedWe'll notify you here with news aboutTurn on desktop notifications for breaking stories about interest? OffOnStream onFDA official who scrutinized COVID shots and antidepressants is out in latest shake-upThe Food and Drug Administration's top drug official is leaving in the latest shake-up at the powerful health agencyByMATTHEW PERRONE AP health writerMay 16, 2026, 12:28 AM1:10FILE - Dr. Tracy Beth Hoeg, with the FDA, listens during a meeting of the Advisory Committee in Immunization Practices at the CDC, June 25, 2025, in Atlanta.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at ABC News — US.
Discussion
0 commentsMore from ABC News — US
